Addressing the Unmet Need for Novel Safe and Effective Pain Therapies
EicOsis is poised to meet an urgent medical need for effective analgesics for pain. Pain can have a devastating impact on someone’s personal and professional life, their quality of life and their emotional and social health. Currently available therapies are often not effective and have common and sometimes serious side effects that limit their use. EicOsis aims to provide a new effective oral analgesic solution for pain management without the side effects of standard pain therapies and without addiction potential. Our lead drug candidate EC5026 is currently undergoing Phase 1 clinical trials. Contact us for more information and to learn more about what’s going on at EicOsis.